CVRx (United States)

Institution (Company)

Homepage ROR

Also Known As

CVRx (United States)

119

Publications

6.6K

Citations

Authors

Concepts

About

CVRx (United States) is a company institution in Minneapolis, United States known for medicine, hypertension, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	35	2.1K
2	Health Sciences	5	11	284
3	Education	1	1	19
4	Engineering	1	1	12
5	Natural Sciences	1	1	102

CVRx (United States)

119

Publications

6.6K

Citations

Page 1

	Year	Citations
Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial Uta C. Hoppe, Mathias C. Brandt, Rolf Wachter, Journal of the American Society of Hypertension HypertensionHeart FailureInvasive SystemCardiovascular DiseaseAntihypertensive Therapy	2012	284
Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction William T. Abraham, Michael R. Zile, Fred A. Weaver, JACC Heart Failure	2015	276
Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial George L. Bakris, Mitra K. Nadim, Hermann Haller, Journal of the American Society of Hypertension Non-pharmacological InterventionHypertensionHeart FailureDurable BenefitCardiovascular Disease	2012	241
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction Michael R. Zile, JoAnn Lindenfeld, Fred A. Weaver, Journal of the American College of Cardiology	2020	192
Chronic Baroreflex Activation Effects on Sympathetic Nerve Traffic, Baroreflex Function, and Cardiac Haemodynamics in Heart Failure: A Proof-of-Concept Study Edoardo Gronda, Gino Seravalle, Gianmaria Brambilla, European Journal of Heart Failure	2014	179
Chronic Baroreceptor Activation Enhances Survival in Dogs With Pacing-Induced Heart Failure Irving H. Zucker, Johnnie Hackley, Kurtis G. Cornish, Hypertension	2007	142
An Implantable Carotid Sinus Baroreflex Activating System: Surgical Technique and Short-Term Outcome from a Multi-Center Feasibility Trial for the Treatment of Resistant Hypertension Jan H.M. Tordoir, Ingrid Scheffers, Jürg Schmidli, European Journal of Vascular and Endovascular Surgery HypertensionResistant HypertensionCardiovascular DiseaseVascular SurgerySurgery	2007	123
Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex Thomas E. Lohmeier, Radu Iliescu, Terry Dwyer, American Journal of Physiology-Heart and Circulatory Physiology	2010	104
Conformational Flexibility in Crystal Structures of Human 11β-Hydroxysteroid Dehydrogenase Type I Provide Insights into Glucocorticoid Interconversion and Enzyme Regulation David J. Hosfield, Yiqin Wu, R.J. Skene, Journal of Biological Chemistry Enzyme Active SiteAldehyde DehydrogenaseBiochemistryProtein AssemblyProtein Folding	2004	102
Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Cardiac Resynchronization Therapy Michael R. Zile, William T. Abraham, Fred A. Weaver, European Journal of Heart Failure	2015	97

Page 1